Amiodarone paradox: Hyperthyroxinemia without thyrotoxicosis – a management strategy analysis based on two clinical cases
Therapy · 26.06.2026 · 4_2026 · 176-182
DOI: 10.18565/therapy.2026.4.176-182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapy, erschienen am 26.06.2026. Verfasst von A.N. Zvyagintseva Zvyagintseva und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zvyagintseva, A. Z., Melkozerov, K. M., Bondarenko, I. B., Shatskaya, O. S., Khamnagadaev, I. K., Kalashnikov, V. K., Platonova, N. P., & Mokrysheva, N. M. (2026). Amiodarone paradox: Hyperthyroxinemia without thyrotoxicosis – a management strategy analysis based on two clinical cases. Therapy, 4_2026, 176-182. https://doi.org/10.18565/therapy.2026.4.176-182
Vancouver
Zvyagintseva AZ, Melkozerov KM, Bondarenko IB, Shatskaya OS, Khamnagadaev IK, Kalashnikov VK, et al. Amiodarone paradox: Hyperthyroxinemia without thyrotoxicosis – a management strategy analysis based on two clinical cases. Therapy. 2026;4_2026:176-182. doi:10.18565/therapy.2026.4.176-182
BibTeX
@article{Zvyagintseva2026,
author = {Zvyagintseva, A.N. Zvyagintseva and Melkozerov, K.V. Melkozerov and Bondarenko, I.Z. Bondarenko and Shatskaya, O.A. Shatskaya and Khamnagadaev, I.A. Khamnagadaev and Kalashnikov, V.Yu. Kalashnikov and Platonova, N.M. Platonova and Mokrysheva, N.G. Mokrysheva},
title = {Amiodarone paradox: Hyperthyroxinemia without thyrotoxicosis – a management strategy analysis based on two clinical cases},
journal = {Therapy},
year = {2026},
volume = {4_2026},
pages = {176--182},
doi = {10.18565/therapy.2026.4.176-182}
}
EUVIMED